NTLA icon

Intellia Therapeutics

318 hedge funds and large institutions have $3.81B invested in Intellia Therapeutics in 2022 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 113 increasing their positions, 96 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
318
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$48.5M
Puts
$38.2M
Net Calls
Net Calls Change

Top Buyers

1 +$17.9M
2 +$16.8M
3 +$16.5M
4
Morgan Stanley
Morgan Stanley
New York
+$16.5M
5
WP
Woodline Partners
California
+$16.2M

Top Sellers

1 -$38M
2 -$25.6M
3 -$25.5M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$21M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$19.4M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$4.7M
77
$4.69M
78
$4.64M
79
$4.61M
80
$4.01M
81
$3.99M
82
$3.83M
83
$3.82M
84
$3.8M
85
$3.72M
86
$3.53M
87
$3.41M
88
$3.31M
89
$3.16M
90
$3.01M
91
$2.89M
92
$2.74M
93
$2.64M
94
$2.5M
95
$2.46M
96
$2.35M
97
$2.32M
98
$2.24M
99
$2.23M
100
$2.22M